News Articles and Montana BioScience Alliance Newsletters
Alercell has launched a new website—Lena Diagnostics, www.lenadx.com—dedicated to proprietary tests focused on early detection of cancer and leukemia.
A National Institutes of Health research group with extensive experience studying ebolavirus countermeasures has successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine.
For over 20 years Golden Helix has been a software company that innovates genetic analysis software for next-generation sequencing (NGS) – and, believing that its customers and employees are at the heart of its success, it has built a glowing reputation as the industry leader in its field.
Inimmune is a leader in the discovery and development of vaccine adjuvants with over 20 years of expertise in their safe and effective use.
The University of Montana was named a top-tier “R1” research institution last year. It was the culmination of a decades-long goal for UM, and the science surge has only gained momentum in the first six months of the 2022-23 fiscal year.
When her husband was undergoing cancer treatment, Cindy Perez of Southwest Ranches, Fla., learned about a new blood test that could help find early cancers. The 50-year-old said she felt fine, but her husband urged her to take the test anyway.
Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.
As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year.
Administrative Supplements to Promote Diversity in Research and Development Small Businesses – SBIR/STTR
Contract Pre-solicitation for R&D that will contribute toward ARPA-H mission needs and SBIR program objectives.
View the Spring 2024 Newsletter now!
View the Winter II 2024 Newsletter now!